Theriva Biologics Inc (TOVX)
1.44
-0.04
(-2.70%)
USD |
NYAM |
Oct 31, 16:00
1.95
+0.51
(+35.42%)
After-Hours: 19:12
Theriva Biologics Cash from Investing (Quarterly): -0.001M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -0.001M |
March 31, 2024 | 0.00 |
December 31, 2023 | -0.056M |
September 30, 2023 | -0.129M |
June 30, 2023 | -0.009M |
March 31, 2023 | -0.008M |
December 31, 2022 | -0.091M |
September 30, 2022 | -0.011M |
June 30, 2022 | -0.014M |
March 31, 2022 | -4.28M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -0.014M |
December 31, 2020 | -0.005M |
September 30, 2020 | -0.004M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -0.007M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
Date | Value |
---|---|
March 31, 2018 | 0.00 |
December 31, 2017 | -0.003M |
September 30, 2017 | -0.198M |
June 30, 2017 | 0.00 |
March 31, 2017 | -0.011M |
December 31, 2016 | -0.37M |
September 30, 2016 | -0.154M |
June 30, 2016 | -0.001M |
March 31, 2016 | -0.044M |
December 31, 2015 | -0.044M |
September 30, 2015 | -0.396M |
June 30, 2015 | -0.043M |
March 31, 2015 | -0.018M |
December 31, 2014 | -0.005M |
September 30, 2014 | -0.022M |
June 30, 2014 | -0.017M |
March 31, 2014 | -0.004M |
December 31, 2013 | -0.011M |
September 30, 2013 | -0.012M |
June 30, 2013 | -0.01M |
March 31, 2013 | -0.003M |
December 31, 2012 | -0.003M |
September 30, 2012 | -0.007M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.28M
Minimum
Mar 2022
--
Maximum
Dec 2019
-0.2433M
Average
-0.005M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
BioCardia Inc | -0.003M |
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | -0.0049M |
iBio Inc | -0.144M |
Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.452M |
Cash from Financing (Quarterly) | 1.773M |
Free Cash Flow | -18.01M |
Free Cash Flow Per Share (Quarterly) | -4.451 |
Free Cash Flow Yield | -1.77K% |